Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes

Cell Metabolism

Volumn 16, Issue 5, 2012, Pages 625-633

  Mahdi, Taman ^a   Hänzelmann, Sonja ^a,b,c   Salehi, Albert ^a   Muhammed, Sarheed J ^a   Reinbothe, Thomas M ^a   Tang, Yunzhao ^a,d   Axelsson, Annika S ^a   Zhou, Yuedan ^a   Jing, Xingjun ^a   Almgren, Peter ^a   Krus, Ulrika ^a   Taneera, Jalal ^a   Blom, Anna M ^a   Lyssenko, Valeriya ^a   Esguerra, Jonathan Lou S ^a   Hansson, Ola ^a   Eliasson, Lena ^a   Derry, Jonathan ^e   Zhang, Enming ^a   Wollheim, Claes B ^a,f   Groop, Leif ^a   Renström, Erik ^a   Rosengren, Anders H ^a,e   more..

^a LUND UNIVERSITY   (Sweden)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d BEIJING HOSPITAL   (China)

^e SAGE BIONETWORKS   (United States)

^f UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM CHANNEL; GLUCOSE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; SECRETED FRIZZLED RELATED PROTEIN 4;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; EXOCYTOSIS; FEMALE; GENE OVEREXPRESSION; GENETIC CODE; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RELEASE; MAJOR CLINICAL STUDY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET CELL DYSFUNCTION; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL;

EID: 84871426151     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.10.009     Document Type: Article

References (43)

1. Albert, R., Jeong, H., and Barabasi, A.L. (2000). Error and attack tolerance of complex networks. Nature 406, 378-382.
2. Bafico, A., Gazit, A., Pramila, T., Finch, P.W., Yaniv, A., and Aaronson, S.A. (1999). Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J. Biol. Chem. 274, 16180-16187.
3. Barabasi, A.L., and Albert, R. (1999). Emergence of scaling in random networks. Science 286, 509-512.
4. Barabási, A.L., Gulbahce, N., and Loscalzo, J. (2011). Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56-68.
5. Berndt, T., Craig, T.A., Bowe, A.E., Vassiliadis, J., Reczek, D., Finnegan, R., Jan De Beur, S.M., Schiavi, S.C., and Kumar, R. (2003). Secreted frizzledrelated protein 4 is a potent tumor-derived phosphaturic agent. J. Clin. Invest. 112, 785-794.
6. Bovolenta, P., Esteve, P., Ruiz, J.M., Cisneros, E., and Lopez-Rios, J. (2008). Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci. 121, 737-746.
7. Braun, M., Ramracheya, R., Bengtsson, M., Zhang, Q., Karanauskaite, J., Partridge, C., Johnson, P.R., and Rorsman, P. (2008). Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes 57, 1618-1628.
8. Carmon, K.S., and Loose, D.S. (2008). Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol. Cancer Res. 6, 1017-1028.
9. Carter, S.L., Brechbühler, C.M., Griffin, M., and Bond, A.T. (2004). Gene co-expression network topology provides a framework for molecular characterization of cellular state. Bioinformatics 20, 2242-2250.
10. Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M.A., Kurz-Levin, M., Zayed, H., Solinger, A.M., Mandrup-Poulsen, T., Dinarello, C.A., and Donath, M.Y. (2012). Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35, 1654-1662.
11. da Silva Xavier, G., Loder, M.K., McDonald, A., Tarasov, A.I., Carzaniga, R., Kronenberger, K., Barg, S., and Rutter, G.A. (2009). TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 58, 894-905.
12. Dinarello, C.A., Donath, M.Y., and Mandrup-Poulsen, T. (2010). Role of IL-1beta in type 2 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17, 314-321.
13. Feng, C., Araki, M., Kunimoto, R., Tamon, A., Makiguchi, H., Niijima, S., Tsujimoto, G., and Okuno, Y. (2009). GEM-TREND: a web tool for gene expression data mining toward relevant network discovery. BMC Genomics 10, 411.
14. Gelebart, P., Anand, M., Armanious, H., Peters, A.C., Dien Bard, J., Amin, H.M., and Lai, R. (2008). Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood 112, 5171-5179.
15. Grant, S.F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006). Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320-323.
16. Groop, L., Forsblom, C., Lehtovirta, M., Tuomi, T., Karanko, S., Nissén, M., Ehrnström, B.O., Forsén, B., Isomaa, B., Snickars, B., and Taskinen, M.R. (1996). Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45, 1585-1593.
17. Heller, R.S., Dichmann, D.S., Jensen, J., Miller, C., Wong, G., Madsen, O.D., and Serup, P. (2002). Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation. Dev. Dyn. 225, 260-270.
18. Helqvist, S., Bouchelouche, P., Andersen, H.U., and Nerup, J. (1989). Modulation of calcium flux influences interleukin 1 beta effects on insulin release from isolated islets of Langerhans. Acta Endocrinol. (Copenh.) 121, 447-455.
19. Igoillo-Esteve, M., Marselli, L., Cunha, D.A., Ladriere, L., Ortis, F., Grieco, F.A., Dotta, F., Weir, G.C., Marchetti, P., Eizirik, D.L., and Cnop, M. (2010). Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53, 1395-1405.
20. Lander, E.S. (2011). Initial impact of the sequencing of the human genome. Nature 470, 187-197.
21. Larsen, C.M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J.A., Seifert, B., Mandrup-Poulsen, T., and Donath, M.Y. (2007). Interleukin-1- receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526.
22. Lee, S.H., Demeterco, C., Geron, I., Abrahamsson, A., Levine, F., and Itkin- Ansari, P. (2008). Islet specific Wnt activation in human type II diabetes. Exp. Diabetes Res. 2008, 728763.
23. Liu, T., DeCostanzo, A.J., Liu, X., Wang Hy, Hallagan, S., Moon, R.T., and Malbon, C.C. (2001). G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science 292, 1718-1722.
24. Ma, L., and Wang, H.Y. (2007). Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway. J. Biol. Chem. 282, 28980-28990.
25. Park, J.R., Jung, J.W., Lee, Y.S., and Kang, K.S. (2008). The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissuederived mesenchymal stem cells. Cell Prolif. 41, 859-874.
26. Rabuazzo, A.M., Buscema, M., Caltabiano, V., Anello, M., Degano, C., Patane, G., Vigneri, R., and Purrello, F. (1995). Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway. Diabetologia 38, 779-784.
27. Rattner, A., Hsieh, J.C., Smallwood, P.M., Gilbert, D.J., Copeland, N.G., Jenkins, N.A., and Nathans, J. (1997). A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc. Natl. Acad. Sci. USA 94, 2859-2863.
28. Ravasz, E., Somera, A.L., Mongru, D.A., Oltvai, Z.N., and Barabási, A.L. (2002). Hierarchical organization of modularity in metabolic networks. Science 297, 1551-1555.
29. Rorsman, P., and Renström, E. (2003). Insulin granule dynamics in pancreatic beta cells. Diabetologia 46, 1029-1045.
30. Rosengren, A.H., Jokubka, R., Tojjar, D., Granhall, C., Hansson, O., Li, D.Q., Nagaraj, V., Reinbothe, T.M., Tuncel, J., Eliasson, L., et al. (2010). Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327, 217-220.
31. Salic, A.N., Kroll, K.L., Evans, L.M., and Kirschner, M.W. (1997). Sizzled: a secreted Xwnt8 antagonist expressed in the ventral marginal zone of Xenopus embryos. Development 124, 4739-4748.
32. Samad, T.A., Moore, K.A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J.V., and Woolf, C.J. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410, 471-475.
33. Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Chen, H., Roix, J.J., Kathiresan, S., Hirschhorn, J.N., Daly, M.J., et al.; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336.
34. Schadt, E.E. (2009). Molecular networks as sensors and drivers of common human diseases. Nature 461, 218-223.
35. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885.
36. Suzuki, H., Watkins, D.N., Jair, K.W., Schuebel, K.E., Markowitz, S.D., Chen, W.D., Pretlow, T.P., Yang, B., Akiyama, Y., Van Engeland, M., et al. (2004). Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36, 417-422.
37. Taneera, J., Lang, S., Sharma, A., Fadista, J., Zhou, Y., Ahlqvist, E., Jonsson, A., Lyssenko, V., Vikman, P., Hansson, O., et al. (2012). A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 16, 122-134.
38. Thaik, C.M., Calderone, A., Takahashi, N., and Colucci, W.S. (1995). Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J. Clin. Invest. 96, 1093-1099.
39. Uren, A., Reichsman, F., Anest, V., Taylor, W.G., Muraiso, K., Bottaro, D.P., Cumberledge, S., and Rubin, J.S. (2000). Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J. Biol. Chem. 275, 4374-4382.
40. Voight, B.F., Scott, L.J., Steinthorsdottir, V., Morris, A.P., Dina, C., Welch, R.P., Zeggini, E., Huth, C., Aulchenko, Y.S., Thorleifsson, G., et al.; MAGIC investigators; GIANT Consortium. (2010). Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579-589.
41. Wisniewska, M.B., Misztal, K., Michowski, W., Szczot, M., Purta, E., Lesniak, W., Klejman, M.E., Dabrowski, M., Filipkowski, R.K., Nagalski, A., et al. (2010). LEF1/beta-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain. J. Neurosci. 30, 4957-4969.
42. Zeggini, E., Scott, L.J., Saxena, R., Voight, B.F., Marchini, J.L., Hu, T., de Bakker, P.I., Abecasis, G.R., Almgren, P., Andersen, G., et al.; Wellcome Trust Case Control Consortium. (2008). Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40, 638-645.
43. Zhang, B., and Horvath, S. (2005). A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4, Article17.